News | February 17, 2015

WPE First Proton Center in Europe to Treat with RayStation

First patient treated was four-year-old boy with malignant brain tumor

RayStation, Raysearch, WPE, Germany, proton therapy, radiation

February 17, 2015 — RaySearch Laboratories AB announced that Westdeutsches Protonentherapiezentrum Essen (WPE) in Germany, a subsidiary of University Hospital Essen, has commenced routine clinical operations with the RayStation treatment planning system from RaySearch. The first clinical treatment generated with the help of RayStation was carried out in January 2015 and the first patient was a four-year-old boy with a malignant brain tumor who received radiation therapy for the entire craniospinal volume.

WPE, being the first university-based proton therapy center in Germany with three gantries and one fixed beam line, started treating patients in mid-2013 and has to date treated more than 150 patients with proton beam therapy. The tumor is irradiated with high precision by scanned or scattered proton beams; the radiation dose can thereby be delivered more precisely and as a result, the unwanted dose to healthy tissues is reduced, leading to a risk reduction of treatment-related side effects.

The RayStation functionality specification for WPE spans the entire spectrum of advanced treatment planning such as model-based segmentation, atlas-based segmentation, robust optimization, deformable registration, dose accumulation and treatment adaptation.

Prof. Beate Timmermann, M.D., medical director at WPE, commented: “With RayStation we’re able to manage more types of cancer than before. This gives hope to patients with tumors in the central nervous system or sarcomas among others. A development like this was only possible due to the intense partnership between our doctors and physicists and the staff of RaySearch.”

Prof. mult Eckhard Nagel, M.D., medical director of the University Hospital Essen, added: “We are very proud that WPE is the first proton therapy center in Europe that uses RayStation. This offers us the possibility to help much more patients with cancer than before and opens the way for successful cancer therapies even under difficult conditions.”

For more information: www.raysearchlabs.com

Related Content

Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...